Protein O-GlcNAcylation and cardiovascular (patho)physiology
- PMID: 25336635
- PMCID: PMC4263852
- DOI: 10.1074/jbc.R114.585984
Protein O-GlcNAcylation and cardiovascular (patho)physiology
Abstract
Our understanding of the role of protein O-GlcNAcylation in the regulation of the cardiovascular system has increased rapidly in recent years. Studies have linked increased O-GlcNAc levels to glucose toxicity and diabetic complications; conversely, acute activation of O-GlcNAcylation has been shown to be cardioprotective. However, it is also increasingly evident that O-GlcNAc turnover plays a central role in the delicate regulation of the cardiovascular system. Therefore, the goals of this minireview are to summarize our current understanding of how changes in O-GlcNAcylation influence cardiovascular pathophysiology and to highlight the evidence that O-GlcNAc cycling is critical for normal function of the cardiovascular system.
Keywords: Calcium; Cardiac Hypertrophy; Cardiovascular; Epigenetics; O-Linked N-Acetylglucosamine (O-GlcNAc).
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.
Figures
References
-
- Marshall S., Bacote V., Traxinger R. R. (1991) Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J. Biol. Chem. 266, 4706–4712 - PubMed
-
- Torres C. R., Hart G. W. (1984) Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J. Biol. Chem. 259, 3308–3317 - PubMed
-
- Roquemore E. P., Chevrier M. R., Cotter R. J., Hart G. W. (1996) Dynamic O-GlcNAcylation of the small heat shock protein αB-crystallin. Biochemistry 35, 3578–3586 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
